acetyl l carnitine hepatic encephalopathy trial Acetyl-L-Carnitine 500 mg A comparative study of acetyl-l-carnitine

Haloacetamidine-based inactivators of protein arginine deiminase 4 (PAD4): evidence that general acid catalysis promotes efficient inactivation

It adds a 13-amino-acid extension at the N-terminus and substitutes arginine for glutamic acid at position 3, which sharply reduces its binding to IGF binding proteins [1] [2]

The occurrence of rotenone in the peruvian fish poison cube

Drug resistance mechanisms beyond DPP9-NRF2 (255) and AIM2-FOXO3a (258) are also underexploredwhether epigenetic modifications (e.g., DNA methylation of ACSL4), post-translational regulation (e.g., GPX4 ubiquitination), or metabolic rewiring (e.g., alternative antioxidant pathways) drives acquired resistance to ferroptosis inducers requires investigation